28 May 2021
- Key lesson from the coronavirus pandemic is the need for partnership between academic excellence, industry and public health organisations
- Centre will unite disciplines, and sectors, to build agile, equitable partnerships that can tackle complex problems and respond to pandemic threats at any time
- Centre will build on the UK and international reach of Oxford’s research collaborations
The University of Oxford has today announced the launch of a new centre of global research collaboration and excellence, the Pandemic Sciences Centre.
The Pandemic Sciences Centre, which will include a number of core institutes, will harness the strong global research collaborations that the University of Oxford has developed over more than forty years. Its mission will be to ensure that the world is better equipped to create global, and equitable science-driven solutions to prepare for, identify, and counter future pandemic threats. The new centre will also build on the strong and unique collaborations developed in record time across national borders between academia, industry and public health bodies during the coronavirus pandemic.
Louise Richardson, Vice-Chancellor of the University of Oxford, said:
‘The recent pandemic has demonstrated the unique contributions research universities like Oxford can make to pandemic preparedness. We are building on decades of medical research on infectious disease and data science, we have longstanding international partnerships and we have the ability to act and to adapt quickly. When aligned with industry and with public health bodies we can ensure that the world is never caught unprepared again.’
Within Oxford, the centre will draw together academics and experts from across its research and innovation community, including from infectious diseases, vaccinology, immunology, structural biology, diagnostics, drug discovery, clinical trials, data science, public health, and social and political sciences. Nationally and internationally, the Centre will foster a multisectoral approach and invest in agile platforms and partnerships.
The centre will focus on three core themes:
- Accelerating understanding and insights: generating actionable knowledge and data (from pathogens through to patients) in near ‘real-time’ and making this globally accessible.
- Translating research into real-world solutions: creating and deploying effective, acceptable and equitable health technologies, including digital tools, diagnostics, treatments, and vaccines.
- Enhancing confidence, trust and impact: identifying ways to strengthen societal and political engagement, resilience, and responsiveness.
Professor Sir John Bell, Regius Professor of Medicine at Oxford University, said:
‘It would be easy to ignore just how much more serious a pandemic could have been this time around - other highly pathogenic viruses carry mortalities of 35-50% - imagine if we had a pandemic where one in three infected people died.
The University of Oxford is uniquely capable of leading a global step change in how we respond to the threat of emerging infections. By investing in sound science now, we can help to safeguard our resilience, global economic stability and health security for generations to come. We are ready to take our vision to build on these foundations to ensure society is better prepared and agile in its response to future threats.’
The inaugural Director of the centre will be Peter Horby, Professor of Emerging Infectious Diseases at the University of Oxford, who has worked on many global health threats including SARS-1, bird flu, Middle East Respiratory Syndrome, Ebola, Lassa fever, and plague.
Professor Peter Horby, inaugural Director of the Pandemic Sciences Centre, said:
‘The COVID-19 pandemic has shown us that spectacular advances are possible through an alliance of science, the public sector and industry – creating digital disease control tools, diagnostic tests, and life-saving treatments and vaccines at unprecedented speed. But it should not take a pandemic to make this happen. This level of innovation and multi-sectoral collaboration must be applied, day in and day out, to prevent another catastrophe like COVID-19.’
The next few months will see significant activity to support the Centre’s development and engage our partners in this exciting initiative as the University looks to secure over £500 million to invest in this centre – with contributions from philanthropists, corporate partners and governments – to create an entity that will make a real difference to the world.
Notes to editors:
For more on the breadth and depth of Oxford’s contribution to the world’s response to the COVID-19 Pandemic, visit: https://www.ox.ac.uk/annual-review
For high resolution images of our spokespeople, visit: https://www.dropbox.com/sh/rs6br2ynzr2n2p4/AAAZYoqv_Y0pwPxqS0cNbkJfa?dl=0
Note, these must be credited ©University of Oxford / John Cairns
For further information, please contact: email@example.com
The Centre will be supported in part through $7 million from AstraZeneca – link to original story: https://www.ox.ac.uk/news/2020-04-30-landmark-partnership-announced-development-covid-19-vaccine
About Professor Peter Horby, inaugural Director of the Pandemic Sciences Centre:
Professor of Emerging Infectious Diseases at the University of Oxford, Peter Horby has worked on many global health threats including SARS-1, bird flu, Middle East Respiratory Syndrome, Ebola, Lassa fever, and plague.
He is Chair of the Government's New and Emerging Respiratory Virus Threats Advisory Group and a member of the UK Government’s Scientific Advisory Group for Emergencies. Peter is Executive Director of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) and co-director of the RECOVERY trial, which established the value of dexamethasone in COVID-19 treatment.
About the University of Oxford
Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the fifth year running, and at the heart of this success is our ground-breaking research and innovation.
Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research sparks imaginative and inventive insights and solutions.
Through its research commercialisation arm, Oxford University Innovation, Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 200 new companies since 1988. Over a third of these companies have been created in the past three years.